Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia

Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia

US Patent 8394816 · Granted Mar 12, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulating gabarap to modulate immunogenic cell death2024
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
Proteolysis targeting chimeric molecules (PROTACs) with functional handles and u2024
Methods for modulating regulatory T cells, regulatory b cells, and immune respon2024
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Immunogenic peptides specific to BCMA and TACI antigens2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
USP7 inhibitors for treating multiple myeloma2022
USP7 inhibitors for treating multiple myeloma2022